NEW YORK – In recent years, developments in single cell and single molecule techniques have allowed proteomics researchers to characterize the body's immune response with improved depth and resolution.
Much of this research has been focused on immuno-oncology, but as the SARS-CoV-2 outbreak has turned into a pandemic, a number of companies and researchers in this space have turned their attention to better understanding how patients' immune systems respond to the virus.